| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +1.2M | 76.2% | $9.02 | +$10.8M |
| Sells | 13 | -374K | 23.8% | $5.65 | -$2.11M |
| Net | -12 | +826K | 52.5% | +$8.71M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Kevin Tang | Director | $76.6M | +$10.8M | +16.4% | Dec 5, 2024 |
| Peter Greenleaf | Chief Executive Officer, Director | $8.52M | -$711K | -7.7% | Mar 6, 2024 |
| Matthew Maxwell Donley | EVP, Ops & Strategy | $3.22M | -$224K | -6.51% | Mar 6, 2024 |
| Michael Robert Martin | Chief Business Officer | $2.92M | Mar 2, 2023 | ||
| Joseph M. Miller | Chief Financial Officer | $2.78M | -$195K | -6.56% | Mar 6, 2024 |
| Stephen P. Robertson | EVP, General Counsel | $2.49M | -$323K | -11.5% | Mar 6, 2024 |
| Scott Habig | Chief Commercial Officer | $2.42M | -$283K | -10.5% | Aug 6, 2024 |
| Volker Knappertz | EVP, Research and Development | $1.95M | -$168K | -7.94% | Feb 27, 2024 |
| Neil Solomons | Chief Medical Officer | $1.02M | Mar 2, 2022 | ||
| George M. Milne Jr | Director | $887K | May 18, 2023 | ||
| Robert Bindert Huizinga | EVP of Research | $781K | Mar 2, 2022 | ||
| Greg Keenan | Chief Medical Officer | $592K | Nov 7, 2024 | ||
| David R.W. Jayne | Director | $476K | -$28.4K | -5.63% | Nov 21, 2024 |
| Jeffrey A. Bailey | Director | $215K | -$38.4K | -15.2% | Nov 21, 2024 |
| Jill Leversage | Director | $211K | -$32.2K | -13.2% | Nov 21, 2024 |
| Karen L. Smith | Director | $209K | -$44.2K | -17.4% | Nov 21, 2024 |
| Craig Johnson | Director | $174K | Nov 21, 2024 | ||
| Daniel Billen | Director | $162K | -$30.1K | -15.7% | May 21, 2024 |
| Massimilano Colao | Chief Commercial Officer | $152K | Mar 2, 2022 | ||
| Joseph P. Hagan | Director | $135K | May 18, 2023 | ||
| R. Hector MacKay-Dunn | Former Director | $107K | -$32.3K | -23.2% | Sep 9, 2024 |
| Brinda Balakrishnan | Director | $101K | -$2.99K | -2.88% | May 21, 2024 |
| Robert T. Foster | Director | Sep 21, 2023 | |||
| Timothy P. Walbert | Director | May 18, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|